The search for new approaches to treating type 1 plasminogen deficiency

E-ISSN： 1545-5017|65|4|pbc.26922-pbc.26922

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.65, Iss.4, 2018-04, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black tea

International Journal of Molecular Medicine, Vol. 27, Iss. 4, 2011-01 ,pp. : 525-529

Spandidos Publications

Access to resources Recommend Favorite

Clinical Relevance of the Plasminogen Activator Inhibitor Type1 – a Multifaceted Proteolytic Factor

Oncology Research and Treatment, Vol. 24, Iss. 3, 2001-07 ,pp. : 238-244

Karger

Access to resources Recommend Favorite

Four Cases of Bleeding Diathesis in Children due to Congenital Plasminogen Activator Inhibitor-1 Deficiency

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 5, 2000-04 ,pp. : 286-291

Karger

Access to resources Recommend Favorite

Successful Arthroscopic Treatment of Pigmented Villonodular Synovitis of the Knee in a Patient with Congenital Deficiency of Plasminogen Activator Inhibitor-1 and Recurrent Haemarthrosis

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 2, 2001-10 ,pp. : 106-112

Karger

Access to resources Recommend Favorite